Crossmark

Interplay between β-lactamases and new β-lactamase inhibitors

Crossref DOI link: https://doi.org/10.1038/s41579-019-0159-8

Published Online: 2019-03-05

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bush, Karen http://orcid.org/0000-0002-7843-2474
Bradford, Patricia A.
License Information

Text and Data Mining valid from 2019-03-05
More Information

Article History

First Online: 5 March 2019

Change Date: 29 May 2019

Change Type: Correction

Change Date: 30 April 2019

Change Type: Correction

Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Change Details: In figure 1 of the above article, the structure of ETX2514 was missing a double bond and methyl group. This has now been corrected in the PDF and online. The publisher apologizes to the authors and to the readers for this error.

Competing interests

: The authors declare competing interests. K.B. serves as an independent consultant for pharmaceutical and biotechnology companies that discover and develop antimicrobial agents. P.A.B. is an independent consultant for companies that work on antibacterial agents. No support or input for the manuscript was provided by any of the companies for which K.B. or P.A.B. consult.